At Cullinan Oncology, our mission is to create new standards of care for patients with cancer. We discover and develop medicines for high-impact oncology targets through modality-agnostic targeted oncology. We rigorously and rapidly advance only highly differentiated molecules, which has yielded a robust and diversified pipeline.